These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 30981007)

  • 21. Role of hepatitis B surface antibody in seroreversion of hepatitis B surface antigen in patients achieving hepatitis B surface antigen loss with pegylated interferon-based therapy.
    Gao N; Yu H; Zhang J; Mo Z; Chu J; Xie C; Peng L; Gao Z
    J Viral Hepat; 2022 Oct; 29(10):899-907. PubMed ID: 35871534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hepatitis B surface antigen seroclearance: Relationship to hepatitis B e-antigen seroclearance and hepatitis B e-antigen-negative hepatitis.
    Fung J; Wong DK; Seto WK; Kopaniszen M; Lai CL; Yuen MF
    Am J Gastroenterol; 2014 Nov; 109(11):1764-70. PubMed ID: 25244963
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and determinants of spontaneous hepatitis B surface antigen seroclearance and seroconversion in hepatitis B e antigen-negative chronic infection patients: A population-based prospective cohort.
    Zhu L; Zhai X; Wang Q; Jiang J; Peng H; Song C; Ge Z; Qian J; Zhou M; Zhou Y; Xu J; Liu H; Hang D; Hu Z; Shen H; Zhu F
    J Viral Hepat; 2018 Dec; 25(12):1588-1598. PubMed ID: 30112835
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Predictive value of intrahepatic hepatitis B virus covalently closed circular DNA and total DNA in patients with acute hepatitis B and patients with chronic hepatitis B receiving anti‑viral treatment.
    Ruan P; Zhou B; Dai X; Sun Z; Guo X; Huang J; Gong Z
    Mol Med Rep; 2014 Apr; 9(4):1135-41. PubMed ID: 24566465
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical and virological features of occult hepatitis B in patients with HBsAg seroclearance post-treatment or spontaneously.
    Cheng HR; Kao JH; Wu HL; Chen TC; Tseng TC; Liu CH; Su TH; Chen PJ; Chen DS; Liu CJ
    Liver Int; 2014 Jul; 34(6):e71-9. PubMed ID: 24119014
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Level of Hepatitis B (HB) Core Antibody Associates With Seroclearance of HBV DNA and HB Surface Antigen in HB e Antigen-Seronegative Patients.
    Hu HH; Liu J; Chang CL; Jen CL; Lee MH; Lu SN; Wang LY; Quan Y; Xia NS; Chen CJ; Chen PJ; Yang HI
    Clin Gastroenterol Hepatol; 2019 Jan; 17(1):172-181.e1. PubMed ID: 29753083
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antiviral therapy, HBsAg seroclearance and late recurrence of hepatitis B-related hepatocellular carcinoma.
    Liu SY; Yuan C; Tong XM
    J Hepatol; 2022 Nov; 77(5):1471-1472. PubMed ID: 35863489
    [No Abstract]   [Full Text] [Related]  

  • 28. Hepatitis B surface antigen seroclearance during chronic HBV infection.
    Chu CM; Liaw YF
    Antivir Ther; 2010; 15(2):133-43. PubMed ID: 20386068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Association Between Seroclearance of Hepatitis B Surface Antigen and Long-term Clinical Outcomes of Patients With Chronic Hepatitis B Virus Infection: Systematic Review and Meta-analysis.
    Anderson RT; Choi HSJ; Lenz O; Peters MG; Janssen HLA; Mishra P; Donaldson E; Westman G; Buchholz S; Miller V; Hansen BE
    Clin Gastroenterol Hepatol; 2021 Mar; 19(3):463-472. PubMed ID: 32473348
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Discontinuation of nucleos(t)ide analogues is not associated with a higher risk of HBsAg seroreversion after antiviral-induced HBsAg seroclearance: a nationwide multicentre study.
    Kim MA; Kim SU; Sinn DH; Jang JW; Lim YS; Ahn SH; Shim JJ; Seo YS; Baek YH; Kim SG; Kim YS; Kim JH; Choe WH; Yim HJ; Lee HW; Kwon JH; Lee SW; Jang JY; Kim HY; Park Y; Kim GA; Yang H; Lee HA; Koh M; Lee YS; Kim M; Chang Y; Kim YJ; Yoon JH; Zoulim F; Lee JH
    Gut; 2020 Dec; 69(12):2214-2222. PubMed ID: 32209606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serum interferon-inducible protein 10 levels predict hepatitis B s antigen seroclearance in patients with chronic hepatitis B.
    Wong GL; Chan HL; Chan HY; Tse CH; Chim AM; Lo AO; Wong VW
    Aliment Pharmacol Ther; 2016 Jan; 43(1):145-53. PubMed ID: 26526395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues.
    Yip TC; Wong GL; Chan HL; Tse YK; Lam KL; Lui GC; Wong VW
    J Hepatol; 2019 Mar; 70(3):361-370. PubMed ID: 30367899
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Peg-IFNα-2a Contributed to HBs Antigen Seroclearance in a Patient with Chronic Hepatitis B Administered Nucleic Acid Analogs: A Three-year Follow-up.
    Tadokoro T; Fujita K; Takuma K; Nakahara M; Oura K; Mimura S; Sakamoto T; Nomura T; Tani J; Morishita A; Yoneyama H; Kobara H; Himoto T; Masaki T
    Intern Med; 2021 Jun; 60(12):1835-1838. PubMed ID: 33456036
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Factors associated with spontaneous HBsAg clearance in chronic hepatitis B patients followed at a university hospital.
    Ferreira SC; Chachá SG; Souza FF; Teixeira AC; Santana RC; Villanova MG; Zucoloto S; Ramalho LN; Perdoná GS; Passos AD; Martinelli AL
    Ann Hepatol; 2014; 13(6):762-70. PubMed ID: 25332262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Virological Determinants of Spontaneous Postpartum e Antigen Seroconversion and Surface Antigen Seroclearance in Pregnant Women Infected with Hepatitis B Virus.
    Hu Y; Feng Z; Liu J; Chen J; Zhang S; Zhou YH
    Arch Med Res; 2016 Apr; 47(3):207-13. PubMed ID: 27387022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Predicting Hepatitis B Virus (HBV) Surface Antigen Seroclearance in HBV e Antigen-Negative Patients With Chronic Hepatitis B: External Validation of a Scoring System.
    Liu J; Tseng TC; Yang HI; Lee MH; Batrla-Utermann R; Jen CL; Lu SN; Wang LY; You SL; Chen PJ; Chen CJ; Kao JH
    J Infect Dis; 2015 May; 211(10):1566-73. PubMed ID: 25430663
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Current Knowledge of Occult Hepatitis B Infection and Clinical Implications.
    Yip TC; Wong GL
    Semin Liver Dis; 2019 May; 39(2):249-260. PubMed ID: 30912100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatitis B surface antigen seroconversion is associated with favourable long-term clinical outcomes during lamivudine treatment in HBeAg-negative chronic hepatitis B patients.
    Idilman R; Cinar K; Seven G; Bozkus Y; Elhan A; Bozdayi M; Yurdaydin C; Bahar K
    J Viral Hepat; 2012 Mar; 19(3):220-6. PubMed ID: 22329377
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [HBsAg seroclearance: prognostic value for the response to treatment and the long-term outcome].
    Moucari R; Marcellin P
    Gastroenterol Clin Biol; 2010 Sep; 34 Suppl 2():S119-25. PubMed ID: 21095515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dynamic Characteristics of Serum Hepatitis B Surface Antigen in Chinese Chronic Hepatitis B Patients Receiving 7 Years of Entecavir Therapy.
    Zhang XX; Li MR; Xi HL; Cao Y; Zhang RW; Zhang Y; Xu XY
    Chin Med J (Engl); 2016 Apr; 129(8):929-35. PubMed ID: 27064037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.